We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Rules For Pfizer In Teva's Challenge To Zoloft Patent

Law360 (January 23, 2005, 12:00 AM EST) -- In a closely watched test of key provisions of the Hatch-Waxman Act, the U.S. Court of Appeals for the Federal Circuit has ruled for Pfizer in a lawsuit brought by Israeli generic manufacturer Teva Pharmaceuticals that challenged the patent for the antidepressant Zoloft.

Teva Pharmaceutical Industries Ltd. sought to challenge Pfizer's patent on a method of making Zoloft so that the company could begin selling a generic version when the patent protecting the chemical composition of the drug expired in 2006.

The U.S. Court of Appeals...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.